美国 · 交易所与实时行情 · Nasdaq
Zymeworks Authorized To Buy Back Up To $200 Mln Of Shares
详细摘要
(RTTNews) - Zymeworks Inc. (ZYME), a biotechnology company, said Monday that its Board has authorized a second share repurchase program of up to $200 million, which is expected to…
MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.nasdaq.com)


